文献速递神经肿瘤功能神经外科

运动定位技术辅助中央区弥漫性胶质瘤切除

Motor mapping to enable resections of peri-rolandic diffuse gliomas.
PubMed 文献 · J Neurooncol · 2026-07-13

该单中心回顾性研究分析了130例中央区胶质瘤患者,比较清醒与睡眠运动定位及两种睡眠定位技术。3个月新发或加重神经功能缺损率在清醒与睡眠组间相当(5.6% vs. 5.3%,p=1.000),IDH突变组均无缺损,支持睡眠定位作为清醒开颅不可行时的合理替代。

要点

  • 清醒与睡眠运动定位的3个月缺损率相当(5.6% vs. 5.3%)。
  • IDH突变胶质瘤患者中两种定位方式均无神经功能缺损。
  • 手持探头与硬膜下电极定位的3个月缺损率相似(3.3% vs. 16.7%)。

核心结论

  • 清醒与睡眠运动定位在胶质瘤各亚型中神经功能结局相当,支持睡眠定位作为清醒开颅不可行时的合理替代。

研究设计与样本

  • 单中心回顾性队列研究,纳入130例接受术中运动定位的中央区胶质瘤切除术患者。
  • 按定位方式分为清醒组(n=54)和睡眠组(n=76),并按WHO 2021分子分型分层。
  • 睡眠组内进一步比较手持探头(HHP-DCS,n=61)与硬膜下电极直接皮层刺激(SDE-DCS,n=12)。

主要发现

  • 3个月新发或加重神经功能缺损率清醒组与睡眠组分别为5.6%和5.3%(p=1.000)。
  • 胶质母细胞瘤(GBM)患者中,睡眠组术前和术后KPS显著较低(p<0.001和p=0.002),但KPS变化值和3个月缺损率无差异。
  • IDH突变胶质瘤患者中两组均无神经功能缺损。
  • GBM患者中两种定位方式的无进展生存和总生存相当。
  • HHP-DCS与SDE-DCS的3个月缺损率分别为3.3%和16.7%(p=0.124)。

临床怎么用

  • 当清醒开颅不可行时,可考虑采用睡眠运动定位技术辅助中央区胶质瘤切除。
  • 睡眠定位下可选择手持探头或硬膜下电极进行直接皮层刺激,两者安全性似相当。

局限性

  • 回顾性数据不能确立统计学等效性。
  • 样本量有限,尤其SDE-DCS亚组仅12例。
  • 需更大规模前瞻性研究确认上述发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intraoperative motor mapping is essential for maximum safe resection of peri-Rolandic gliomas. While both awake and asleep techniques have demonstrated efficacy in preserving neurological function, comparative outcomes across WHO 2021 molecular tumor subtypes remain poorly defined. We compare outcomes between these mapping modalities in glioblastoma (GBM) and IDH-mutant gliomas. METHODS: A 130-patient cohort undergoing peri-Rolandic glioma resection with intraoperative motor mapping at a single institution was analyzed. Patients were stratified by mapping modality (awake n = 54, asleep n = 76) and tumor subtype (WHO 2021). Within the asleep cohort, handheld probe (HHP-DCS, n = 61) and subdural electrode direct cortical stimulation (SDE-DCS, n = 12) were compared. The primary outcome was new or worsening neurological deficits at 3 months. Secondary outcomes included Karnofsky Performance Status (KPS), hospital length of stay, discharge disposition, and survival in GBM patients. RESULTS: Three-month deficit rates were comparable between awake and asleep mapping (5.6% vs. 5.3%, p = 1.000). In GBM patients, pre- and postoperative KPS were significantly lower in the asleep group (p < 0.001 and p = 0.002), though delta KPS and 3-month deficit rates did not differ. No deficits occurred in either group among IDH-mutant gliomas. Progression-free and overall survival were comparable between mapping modalities in GBM. HHP-DCS and SDE-DCS produced similar 3-month deficit rates (3.3% vs. 16.7%, p = 0.124). CONCLUSION: Awake and asleep motor mapping were associated with comparable neurological outcomes across glioma subtypes, supporting asleep mapping as a reasonable alternative when awake craniotomy is not feasible, though these retrospective data do not establish statistical equivalence. HHP-DCS and SDE-DCS appear comparable in safety. Larger prospective studies are needed to confirm these findings.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Trippett JS, Dono A, Shams SS, et al. Motor mapping to enable resections of peri-rolandic diffuse gliomas. J Neurooncol. 2026. PMID: 42440190. doi:10.1007/s11060-026-05693-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。